We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
A new paediatric formulation of the Pfizer BioNTech COVID-19 vaccine has been approved for children aged 5 to 11 after meeting the required safety, quality and effectiveness standards.
The UK has signed contracts to buy a further 4.25 million courses of antivirals for the NHS
First published during the 2019 to 2022 Johnson Conservative government
This new guidance follows consultation with stakeholders from the pharmaceutical industry, academic research, trade associations, patient organisations/charities, healthcare providers and regulatory organisations.
The move aims to help accelerate the booster programme and get jabs in arms more quickly in light of rising cases of Omicron.
Boost Day drive launches across all major TV channels to encourage people to get their top-up jab
This monoclonal antibody – the second to be authorised by the Medicines and Healthcare products Regulatory Agency – is for people with mild to moderate COVID-19 who are at high risk of developing severe disease.…
As a precaution, companies are recalling some batches of irbesartan medicines due to presence of a chemical substance (AZBT) in an amount over the limit permitted for this product. Patients taking irbesartan medicines should…
Catching COVID-19 carries far higher risk than having the vaccine and only 22% of women who gave birth in August were vaccinated.
The chance for adults and children suffering from life-threatening allergic reactions to get life-saving shots of adrenaline in public places, such as restaurants and entertainment venues, has come a step closer as a result …
The labelling states an incorrect maximum daily dose for 12-15-year olds. The MHRA, who issued the recall, says that that the risk to patients is very low.
The antiviral was found to be safe and effective following a stringent review of the available evidence.
Dr Laura Squire OBE has begun her role as the Medicines and Healthcare products Regulatory Agency’s (MHRA) Chief Healthcare Quality and Access Officer
People who suspect they may have experienced a side effect from a medicine or vaccine are being encouraged to report it to the Medicines and Healthcare products Regulatory Agency (MHRA) Yellow Card scheme as part of the global #MedSafetyWeek campaign from 1-7 November 2021.
The MHRA is committed to responding to the Tobacco Control Plan and supports the UK Government’s vision for a smoke-free generation by encouraging safe, high-quality and effective e-cigarette products to be licensed as medic…
England could be the first country in the world to prescribe medicinally licensed e-cigarettes to help reduce smoking rates.
The new antivirals could be rolled out through a clinical study from winter.
People are being encouraged to contribute their views on changes to how medical devices will be regulated across the UK.
Vaccine clinical trial participants to be offered additional approved vaccines for international travel from next week.
AWTTC joins the Innovative Licensing and Access Pathway as a permanent partner
Groundbreaking new treatment to be rolled out to vulnerable hospital patients from next week.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).